Deluxe Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 01-01-2025
- Paid Up Capital ₹ 0.50 M
as on 01-01-2025
- Company Age 24 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 4.00 Cr
as on 01-01-2025
- Satisfied Charges ₹ 75.00 Cr
as on 01-01-2025
- Revenue -29.03%
(FY 2021)
- Profit -3772.39%
(FY 2021)
- Ebitda -2050.55%
(FY 2021)
- Net Worth -330.33%
(FY 2021)
- Total Assets -1.06%
(FY 2021)
About Deluxe Laboratories
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹4.00 Cr. The company has closed loans amounting to ₹75.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nilesh Harishchandra and Bharat Bhandari serve as directors at the Company.
- CIN/LLPIN
U70102MH2000PTC128345
- Company No.
128345
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2000
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Deluxe Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Harishchandra  | Additional Director | 12-Sep-2017 | Current |
| Bharat Bhandari | Additional Director | 31-Mar-2019 | Current |
Financial Performance of Deluxe Laboratories.
Deluxe Laboratories Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 29.03% decrease. The company also saw a substantial fall in profitability, with a 3772.39% decrease in profit. The company's net worth observed a substantial decline by a decrease of 330.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deluxe Laboratories?
In 2021, Deluxe Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Shreeraj Buildcon Dev. Private LimitedActive 17 years 6 months
Nilesh Harishchandra is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Dec 2019 | ₹4.00 Cr | Open |
Il & Fs Trust Company Limited Creation Date: 10 Mar 2015 | ₹50.00 Cr | Satisfied |
Il & Fs Trust Company Limited Creation Date: 30 Apr 2013 | ₹25.00 Cr | Satisfied |
How Many Employees Work at Deluxe Laboratories?
Unlock and access historical data on people associated with Deluxe Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deluxe Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deluxe Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
